Shock wave lithotripsy for uric acid stones

Area of Science:

• Urology
• Nephrology
• Medical Technology

Background:

• Uric acid stones are a significant cause of kidney stone disease.
• Extracorporeal shock wave lithotripsy (SWL) is a common treatment modality for kidney stones.
• Optimizing SWL parameters and adjunctive therapies is crucial for improving treatment outcomes.

Purpose of the Study:

• To evaluate the efficacy and safety of SWL for treating uric acid stones.
• To compare treatment outcomes between different SWL devices.
• To assess the impact of urine alkalization on SWL success rates.

Main Methods:

• A retrospective analysis of 443 patients with uric acid stones treated with SWL between 1987 and 2003.
• Patients were treated using either an EDAP LT-01 piezoelectric or a Dornier Compact S electromagnetic lithotripter.
• Ultrasound guidance and alkali therapy were employed during SWL procedures.

Main Results:

• Both lithotripters demonstrated high 3-month stone-free rates (86.4% for EDAP LT-01, 90.3% for Dornier Compact S).
• Retreatment rates were 24.2% and 29.0% respectively.
• Optimal results were observed for stones smaller than 20 mm; no anesthesia was required.

Conclusions:

• SWL with ultrasound localization is a safe and effective treatment for uric acid stones.
• The combination of SWL and urine alkalization shows promise for enhancing stone-free rates.
• Further research may explore optimizing treatment protocols for different stone types and sizes.